Stéphane Mouly
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Internal Medicine top 5%
Papers in
-
- HIV/AIDS drug development and treatment 4
- Surgery 13
- Co-authors
- Jean‐François Bergmann (53 shared papers)Mary F. Paine (1 shared paper)Carmelo Lafuente‐Lafuente (3 shared papers)Célia Lloret‐Linares (17 shared papers)Isabelle Mahé (10 shared papers)Xavier Declèves (10 shared papers)Guy G. Simoneau (20 shared papers)Paul B. Watkins (2 shared papers)
- Journals
- British Journal of Clinical Pharmacology (7 papers)Diabetes & Metabolism (3 papers)Journal of Clinical Medicine (3 papers)Molecular Pharmaceutics (3 papers)Medicine (2 papers)
- Partner nations
- FranceUnited StatesJapan
In The Last Decade
Stéphane Mouly
97 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 134
- Pharmacology 317
- Internal Medicine 66
- Cardiology and Cardiovascular Medicine 388
- Virology 80
- Infectious Diseases 301
Countries citing papers authored by Stéphane Mouly
This map shows the geographic impact of Stéphane Mouly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Mouly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Mouly more than expected).
Fields of papers citing papers by Stéphane Mouly
This network shows the impact of papers produced by Stéphane Mouly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Mouly. The network helps show where Stéphane Mouly may publish in the future.
Co-authors
The 25 scholars most cited alongside Stéphane Mouly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 233 | |
| 2 | 2006 | 199 | |
| 3 | 2002 | 180 | |
| 4 | 2016 | 92 | |
| 5 | 2010 | 81 | |
| 6 | 2007 | 81 | |
| 7 | 2005 | 78 | |
| 8 | 2002 | 73 | |
| 9 | 2009 | 71 | |
| 10 | 2016 | 69 | |
| 11 | 2014 | 62 | |
| 12 | 2016 | 58 | |
| 13 | 2011 | 57 | |
| 14 | 2014 | 55 | |
| 15 | 2008 | 49 | |
| 16 | 2010 | 48 | |
| 17 | 2009 | 47 | |
| 18 | 2012 | 44 | |
| 19 | 2013 | 42 | |
| 20 | 2020 | 39 |
About Stéphane Mouly
Stéphane Mouly is a scholar working on Infectious Diseases, Surgery, Physiology, Epidemiology and Pharmacology, having authored 100 papers that have together received 2.5k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (9 papers), Drug Transport and Resistance Mechanisms (6 papers), Sarcoidosis and Beryllium Toxicity Research (5 papers), Diet and metabolism studies (5 papers), HIV/AIDS drug development and treatment (4 papers), Neurotransmitter Receptor Influence on Behavior (3 papers), Venous Thromboembolism Diagnosis and Management (3 papers) and Pharmaceutical Economics and Policy (3 papers). The work is most often cited by research in Pharmacology (317 citations), Internal Medicine (66 citations), Cardiology and Cardiovascular Medicine (388 citations), Virology (80 citations) and Infectious Diseases (301 citations). Stéphane Mouly has collaborated with scholars based in France, United States and Japan. Frequent co-authors include Jean‐François Bergmann, Mary F. Paine, Carmelo Lafuente‐Lafuente, Célia Lloret‐Linares, Isabelle Mahé, Xavier Declèves, Guy G. Simoneau, Paul B. Watkins, Irma H. Benedek and William D. Fiske. Their work appears in journals such as British Journal of Clinical Pharmacology, Diabetes & Metabolism, Journal of Clinical Medicine, Molecular Pharmaceutics and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.